Elevated Interleukin-38 Level Associates with Clinical Response to Atorvastatin in Patients with Hyperlipidemia | Zendy

Ning Yang | Zendy; Yanqiu Song | Zendy; Bo Dong | Zendy; Yang Li | Zendy; Lu Kou | Zendy; Jingyu Yang | Zendy; Qin Qin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Elevated Interleukin-38 Level Associates with Clinical Response to Atorvastatin in Patients with Hyperlipidemia

Author(s) -

Ning Yang,

Yanqiu Song,

Bo Dong,

Yang Li,

Lu Kou,

Jingyu Yang,

Qin Qin

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000493029

Subject(s) - hyperlipidemia , medicine , atorvastatin , peripheral blood mononuclear cell , endocrinology , inflammation , interleukin , tumor necrosis factor alpha , immunology , cytokine , in vitro , biology , diabetes mellitus , biochemistry

Hyperlipidemia is a risk factor for various cardiovascular and metabolic disorders. And it is tightly related to chronic inflammation. Interleukin-38 (IL-38) represents a new member of anti-inflammatory cytokines. Thus we studied the important role of IL-38 in hyperlipidemia development and treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research